Rallybio Corporation (RLYB)
Nasdaq: RLYB · Pharmaceutical Preparations · New Haven, CT · filing with the SEC since 2018
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
| Report filed | Mar 16, 2026 | Mar 13, 2025 | Mar 12, 2024 | Mar 6, 2023 | Mar 15, 2022 | · |
| Revenue | 858 | 636r | · | · | · | · |
| Research and development | 19,597 | 41,507 | 53,544 | 40,689 | 26,909 | 17,630 |
| General and administrative | 14,325 | 19,625 | 25,388 | 27,195 | 18,739 | 7,673 |
| Total operating expenses | 33,922 | 61,132 | 78,932 | 67,884 | 45,648 | 25,303 |
| Operating income | -33,064 | -60,496 | -78,932 | -67,884 | -45,648 | -25,303 |
| Interest expense | · | · | · | 0 | 10 | 49 |
| Share of profit of equity-method investments | -874 | -2,239 | -2,041 | -1,075 | -1,505 | -1,522 |
| Other income (expense), net | 22,771 | 744 | 262 | 342 | 96 | 241 |
| Total non-operating income (expense) | 24,960 | 4,960 | 6,409 | 2,305 | 140 | 363 |
| Income before income taxes | -8,978 | -55,536 | -72,523 | -65,579 | -45,508 | -24,940 |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | -15 |
| Net income including non-controlling interests | · | · | · | · | -47,013 | -26,447 |
| Net income | -8,978 | -57,775 | -74,564 | -66,654 | -47,013 | -26,447 |
| Earnings per share, basic | -1.59 | -10.61r | -14.72b | -16.72b | -14.72b | · |
| Earnings per share, diluted | -1.59 | -10.61r | -14.72b | -16.72b | -14.72b | · |
| Earnings per share, basic and diluted | · | · | · | · | -14.72b | -12.16b |
| Weighted average shares, basic | 5,629,370 | 5,443,332r | 5,055,924b | 3,977,664b | 3,189,889b | · |
| Weighted average shares, diluted | 5,629,370 | 5,443,332r | 5,055,924b | 3,977,664b | 3,189,889b | · |
| Weighted average shares, basic and diluted | · | · | · | · | 3,189,889b | 2,173,530b |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-8 reverse split.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenuesResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest expense what its borrowing cost
us-gaap:InterestExpenseShare of profit of equity-method investments its share of companies it partly owns
us-gaap:IncomeLossFromEquityMethodInvestmentsOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income including non-controlling interests the whole group's profit, minority holders' share included
us-gaap:ProfitLossNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedEarnings per share, basic and diluted net income per share, where both counts are the same
us-gaap:EarningsPerShareBasicAndDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstandingWeighted average shares, basic and diluted the average count, where both counts are the same
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted